187 related articles for article (PubMed ID: 3776990)
1. Diethylstilbestrol and clear cell vaginal carcinoma. Reappraisal of the epidemiologic evidence.
McFarlane MJ; Feinstein AR; Horwitz RI
Am J Med; 1986 Nov; 81(5):855-63. PubMed ID: 3776990
[TBL] [Abstract][Full Text] [Related]
2. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
Edelman DA
Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
4. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
[TBL] [Abstract][Full Text] [Related]
5. Management of the adolescent girl exposed in utero to DES.
Gerbie MV
Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
[TBL] [Abstract][Full Text] [Related]
6. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
7. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
[TBL] [Abstract][Full Text] [Related]
8. Vaginal cancer: an iatrogenic disease?
Weiss K
Int J Health Serv; 1975; 5(2):235-51. PubMed ID: 1181297
[TBL] [Abstract][Full Text] [Related]
9. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
DeMars LR; Van Le L; Huang I; Fowler WC
Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
[TBL] [Abstract][Full Text] [Related]
10. Role of hormones including diethylstibestrol (DES) in the pathogenesis of cervical and vaginal intraepithelial neoplasia.
Robboy SJ; Truslow GY; Anton J; Richart RM
Gynecol Oncol; 1981 Oct; 12(2 Pt 2):S98-110. PubMed ID: 7030882
[TBL] [Abstract][Full Text] [Related]
11. The current status of the DES-exposed population.
Herbst AL
Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
[TBL] [Abstract][Full Text] [Related]
12. Six years' experience with screening of a diethylstilbestrol-exposed population.
Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
[TBL] [Abstract][Full Text] [Related]
13. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
Huo D; Anderson D; Palmer JR; Herbst AL
Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
[TBL] [Abstract][Full Text] [Related]
14. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
15. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
[TBL] [Abstract][Full Text] [Related]
16. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
[TBL] [Abstract][Full Text] [Related]
17. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
19. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
[TBL] [Abstract][Full Text] [Related]
20. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records.
Sharp GB; Cole P; Anderson D; Herbst AL
Cancer; 1990 Nov; 66(10):2215-20. PubMed ID: 2224777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]